10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
Bispecific Playgrounds? No, Factory Floors
Developers Prepare for Future Biologics Work by Exploring a Multitude of Antibody Formats
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
For full access to this article login to GEN Select now.
Culture Media Purpose-Fit for New Therapies
To Generate New Biologics, You Need Specialty Media—Defined Media, Animal-Component-Free Media, and Other Wonders of Formulation
- Hunger for cell culture media is greatest among developers of traditional biopharmaceuticals. Contributing less to current demand—but demonstrating a growing appetite—are developers of drugs based on antibody and protein variants. Also, developers of nonprotein biological therapeutics are acquiring a taste for cell culture media. If developers of traditional ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.